p53 loss of function is a common occurrence in cancers and often correlates with an unfavorable prognosis, and the germline deletion of p53 in both humans and mice predisposes individuals to an increased cancer incidence (Bieging et al., 2014; Mantovani et al., 2019). This evidence concerns the gene TP53 and cancer.